Ex Parte MeillandDownload PDFPatent Trial and Appeal BoardSep 19, 201313064778 (P.T.A.B. Sep. 19, 2013) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE __________ BEFORE THE PATENT TRIAL AND APPEAL BOARD __________ Ex parte ALAIN A. MEILLAND1 __________ Appeal 2012-002753 Application 13/064,778 Technology Center 1600 __________ Before MELANIE L. McCOLLUM, ERICA A. FRANKLIN, and SHERIDAN K. SNEDDEN, Administrative Patent Judges. McCOLLUM, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 involving claims to a rose plant variety. The Examiner has rejected the claim as anticipated. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. STATEMENT OF THE CASE Claim 1 is on appeal (App. Br. 2). The claim reads as follows: 1. A new and distinct variety of Hybrid Tea rose plant characterized by the following combination of characteristics: 1 Appellant identifies the real party in interest as CP DELAWARE, INC. (App. Br. 2). Appeal 2012-002753 Application 13/064,778 2 (a) exhibits an erect growth habit, (b) exhibits a strong vigorous growth habit, (c) abundantly forms over substantially the entire season attractive large double yellow blossoms that are lightly perfumed, (d) forms decorative dark green semi-glossy foliage that contrasts well with the yellow blossoms, and (e) is particularly well suited for growing as attractive ornamentation in the landscape; substantially as herein shown and described. Claim 1 stands rejected under 35 U.S.C. § 102(b) as anticipated by French Plant Breeder’s Rights Application No. 15434, published April 20, 1997, and European Plant Breeder’s Rights Application No. 19980100, published April 15, 1998, in view of Appellant’s “admission that the cultivar Meitelov was first sold in France in September 1997 . . . [and] was available in the August 1997 catalog of Meilland Richardier” (Ans. 4-5). Appellant argues that the applied printed publications are not enabling and that the plant itself was not made available to the public in the United States until less than one year prior to the effective filing date of the present application (App. Br. 4 & 8). In addition, Appellant argues that the Federal Circuit’s decision in In re Elsner, 381 F.3d 1125 (Fed. Cir. 2004), “is fatally flawed as a matter of law and should not be followed” (id. at 8). FINDINGS OF FACT 1. The present application claims the benefit of an application filed August 28, 2000 (Sub. Spec. 1), which Appellant states is the effective filing date of the present application (App. Br. 3). 2. The present application describes a plant variety that “has been named the ‘Meitelov’ variety” (Sub. Spec. 3). Appeal 2012-002753 Application 13/064,778 3 3. French Plant Breeder’s Rights Application No. 15434 was published on April 20, 1997, and European Plant Breeder’s Rights Application No. 19980100 was published on April 15, 1998 (Ans. 4). 4. It is undisputed that each of these applications discloses, but does not enable, Meitelov (Ans. 4-5; App. Br. 4). 5. It is also undisputed that “the cultivar Meitelov was first sold in France in September 1997 . . . [and] was available in the August 1997 catalog of Meilland Richardier” (Ans. 4-5). PRINCIPLES OF LAW As with utility patents, “only an ‘enabling’ publication is effective as a bar [under 35 U.S.C. § 102(b)] to a subsequent [plant] patent.” In re LeGrice, 301 F.2d 929, 939 (CCPA 1962). However, “evidence of [a] foreign sale of a claimed reproducible plant variety may enable an otherwise non-enabled printed publication disclosing that plant, thereby creating a § 102(b) bar.” In re Elsner, 381 F.3d at 1128. In particular, [w]hen a publication identifies the plant that is invented or discovered and a foreign sale occurs that puts one of ordinary skill in the art in possession of the plant itself, which, based on the level of ordinary skill in the art, permits asexual reproduction without undue experimentation, that combination of facts and events so directly conveys the essential knowledge of the invention that the sale combines with the publication to erect a statutory bar. Id. at 1129. “[T]he precise focus of the analysis is not whether the foreign sales are themselves § 102(b) prior art, but whether the publication has placed the claimed invention in the possession of the public before the critical date.” Id. at 1129-30. In this regard, the Elsner court explained that “[t]he foreign Appeal 2012-002753 Application 13/064,778 4 sale must not be an obscure, solitary occurrence that would go unnoticed by those skilled in the art. Its availability must have been known in the art, just as a printed publication must be publicly available.” Id. at 1131. In addition, the Elsner court explained that, “even if the interested public would readily know of the foreign sales, those sales [must] enable[ ] one of ordinary skill in the art to reproduce the claimed plants without undue experimentation.” Id. ANALYSIS The French and European Applications, which were each published more than a year before the effective filing date of the present application, each disclose the plant recited in claim 1 (Findings of Fact (FF) 1-4). In addition, this plant was publically available (in France) more than a year before the effective filing date of the present application (FF 5). Moreover, the Examiner finds, and Appellant does not dispute, that possession of the plant would enable one of ordinary skill in the art to reproduce the claimed plant without undue experimentation (Ans. 6-7). Thus, in view of In re Elsner, we conclude that the Examiner has set forth a prima facie case that the French and European Applications each anticipate claim 1. In addition, Appellant’s arguments do not persuade us otherwise. With regard to In re LeGrice, we note that the Elsner court specifically discussed this decision, noting that the LeGrice court recognized that “there are inherent differences between plants and manufactured articles.” In re Elsner, 381 F.3d at 1129 (quoting In re LeGrice, 301 F.2d at 935). In addition, as stated in Elsner: LeGrice decided only the narrow issue whether a printed publication of a plant patent that is not enabled is a statutory Appeal 2012-002753 Application 13/064,778 5 bar. That decision did not address the manner in which a publication may be enabled, and it did not decide whether other evidence such as the availability of an invention through foreign sales may be considered in determining whether a printed publication enables a skilled artisan to reproduce a claimed plant. In re Elsner, 381 F.3d at 1130. Thus, we agree with the Examiner that Elsner is controlling. CONCLUSION The evidence supports the Examiner’s conclusion that claim 1 is anticipated. We therefore affirm the anticipation rejection. TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED cdc Copy with citationCopy as parenthetical citation